Preventing peritoneal fibrosis - An ace up our sleeve?

Peritoneal Dialysis International

Volumn 25, Issue 1, 2005, Pages 25-29

  Witowski, Janusz ^a,b   Jörres, Achim ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN I; DIPEPTIDYL CARBOXYPEPTIDASE; FIBRONECTIN; GLUCOSE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; FIBROSIS; HUMAN; MOLECULAR MECHANICS; NONHUMAN; PERITONEAL CAVITY; PERITONEAL DIALYSIS; PERITONEAL DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RECEPTOR BINDING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 15044356173     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080502500106     Document Type: Article

References (26)

1. Carey RM, Siragy HM. Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev 2003; 24: 261-71.
2. Danser AH. Local renin-angiotensin systems: the unanswered questions. Int J Biochem Cell Biol 2003; 35: 759-68.
3. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol 2003; 35:881-900.
4. Varagic J, Frohlich ED. Local cardiac renin-angiotensin system: hypertension and cardiac failure. J Mol Cell Cardiol 2002; 34:1435-42.
5. Brewster UC, Perazella MA. The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease. Am J Med 2004; 116:263-72.
6. Brewster UC, Setaro JF, Perazella MA. The renin-angiotensin-aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states. Am J Med Sci 2003; 326:15-24.
7. Noh H, Ha H, Yu MR, Kim YO, Kim JH, Lee HB. Angiotensin II mediates high glucose-induced TGF-β1 and fibronectin upregulation in HPMC through reactive oxygen species. Perit Dial Int 2005; 25:38-47.
8. Weber KT, Swamynathan SK, Guntaka RV, Sun Y. Angiotensin II and extracellutar matrix homeostasis. Int J Biochem Cell Biol 1999; 31:395-403.
9. Takeda H, Katagata Y, Hozumi Y, Kondo S. Effects of angiotensin II receptor signaling during skin wound healing. Am J Pathol 2004; 165:1653-62.
10. Kuwahara M, Kuwahara M. Involvement of Rho and tyrosine kinase in angiotensin II-induced actin reorganization in mesothelial cells. Eur J Pharmacol 2002; 436: 15-21.
11. Kuwahara M, Miyaji T, Tsubone H. Angiotensin II type 1 receptor-mediated increase in cytosoLic Ca(2+) and proliferation in mesothelial cells. Eur J Pharmacol 2000; 388:21-7.
12. Campbell RC. The renin-angiotensin system: a 21st century perspective. J Am Soc Nephrol 2004; 15: 1963-4.
13. Cheung BM. Blockade of the renin-angiotensin system. Hong Kong Med J 2002; 8:185-91.
14. Wolf G, Butzmann U, Wenzel UO. The renin-angiotensin system and progression of renal disease: from hemodynamics to cell biology. Nephron Physiol 2003; 93:3-13.
15. Schrijvers BF, De Vriese AS, FLyvbjerg A. From hyperglycemia to diabetic kidney disease: the role of metabolic, hemodynamic, intracellular factors and growth factors/cytokines. Endocr Rev 2004; 25:971-1010.
16. Carey RM, Siragy HM. The intrarenal renin-angiotensin system and diabetic nephropathy. Trends Endocrinol Metab 2003; 14:274-81.
17. Hsieh TJ, Zhang SL, Filep JG, Tang SS, IngelfingerJR, Chan JS. High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells. Endocrinology 2002; 143:2975-85.
18. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414:813-20.
19. Hsieh TJ, Fustier P, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, et al. High glucose stimulates angiotensinogen gene expression and cell hypertrophy via activation of the hexosamine biosynthesis pathway in rat kidney proximal tubular cells. Endocrinology 2003; 144:4338-49.
20. Zhang SL, Filep JG, Hohman TC, Tang SS, Ingelfinger JR, Chan JS. Molecular mechanisms of glucose action on angiotensinogen gene expression in rat proximal tubular cells. Kidney Int 1999; 55:454-64.
21. Zhang SL, Tang SS, Chen X, Filep JG, Ingelfinger JR, Chan JS. High levels of glucose stimulate angiotensinogen gene expression via the P38 mitogen-activated protein kinase pathway in rat kidney proximal tubular cells. Endocrinology 20OO; 141:4637-46.
22. Wong TY, Phillips AO, Witowski J, Topley N. Glucose-mediated induction of TGF-beta 1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent. Kidney Int 2003; 63:1404-16.
23. Ha H, Yu MR, Lee HB. High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int 2001; 59:463-70.
24. Lee HB, Yu MR, Song JS, Ha H. Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells. Kidney Int 2004; 65:1170-9.
25. Duman S, Wieczorowska-Tobis K, Styszynski A, Kwiatkowska B, Breborowicz A, OreopouLos DG. Intraperitoneal enalapril ameliorates morphoLogic changes induced by hypertonic peritoneal dialysis solutions in rat peritoneum. Adv Perit Dial 2004; 20:31-6.
26. Duman S, Gunal AI, Sen S, Asci G, Ozkahya M, Terzioglu E. Does enalapril prevent peritoneal fibrosis induced by hypertonic (3.86%) peritoneal dialysis solution? Perit Dial Int 2001; 21:219-24.